May 5 (Reuters) - Cytokinetics said on Tuesday its experimental heart disease drug significantly improved symptoms of a genetic heart condition in a late-stage trial. Shares of the company were up 13.

Critical congenital heart diseases, or CCHDs, are a group of life-threatening structural heart defects present at birth.

Newborns with a heart defect may have two strikes against their future health, rather than one. Babies with heart birth defects appear to have a higher risk of developing childhood cancer, compared to ...

Lifestyle, environment, and genetics can shape heart disease risk, but a new study from UConn researchers explores how ...

Congenital heart disease (CHD) which is a problem with how the heart forms before birth -- occurs in approximately 1 % of ...

In 2016, the U.S. Preventive Services Task Force (USPSTF) gave a ‘B’ grade recommendation for adults aged 50 to 59 with at ...

A Cornwall couple shared their story of navigating their two children's congenital heart conditions to raise awareness. An ...

Add Yahoo as a preferred source to see more of our stories on Google. Nurse Practitioner Aubrey Campbell checks on her 8-month-old patient, Levi Rodriguez, at Texas Children's Hospital in Houston on ...

Many risk factors for cardiovascular conditions exist, including inherited factors. Now, a validation study suggests a new ...

Australia's Murdoch Children's Research Institute is helping scientists use stem cell medicine and artificial intelligence to develop precision therapies for pediatric heart disease, the leading cause ...